Inventiva: share price falls, cash flow concerns
Biopharmaceutical company Inventiva is down 5% on Wednesday's trading on the Paris Bourse, following the announcement of its quarterly results, which were marked by a need for refinancing that...
Stay updated with breaking news from Paris Bourse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biopharmaceutical company Inventiva is down 5% on Wednesday's trading on the Paris Bourse, following the announcement of its quarterly results, which were marked by a need for refinancing that...
Nanobiotix shares were down 4% on the Paris Bourse on Wednesday, after announcing a strategy update in view of the potential commercialization of its lead drug candidate by Janssen, a subsidiary of...
The Paris Bourse is likely to open on a cautious note on Tuesday morning, in a wait-and-see market on the eve of Nvidia's results and the publication of the Fed's latest 'minutes'.At around 8:15 a.m.,...
Eramet announced on Tuesday that it plans to repurchase 300 million euros worth of debt maturing in 2025, with the aim of launching a new sustainability bond issue.The tender is for its entire 300...
NFL Biosciences announced on Tuesday that it had received positive feedback from the FDA, the US health agency, with a view to conducting clinical trials on its drug candidate dedicated to reducing...